1 hour ago |
Daniel Paproth
* did an article on respiratory stocks that featured IVX....
https://**promotion blocked**/healt...piratory-stocks-to-get-you-feeling-breathless
There are more than a dozen ASX stocks focused on the respiratory space — from trying to tackle asthma
A
* review of 13 small cap respiratory stocks has found that the majority are up year-on-year — led by one company that had a stellar 2018 financial year.
Invion (ASX:IVX), which is testing a drug called INV104, is up a huge 1358 per cent over the past 12 months, going from 0.2c to 3.5c earlier today:
https://**promotion blocked**/wp-content/uploads/2018/08/Share-Price-41.jpg
Invion shares (ASX:IVX) over the past year
The drug works by blocking the actions of leukotrienes, preventing the increased mucus production, inflammation and narrowing of the airways that occurs in asthma.
(20min delay)